Cardiovascular Systems Inc (OQ:CSII)

Business Focus: Medical Equipment, Supplies & Distribution

Jan 15, 2020 07:00 am ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Second-Quarter Earnings Conference Call Wednesday, February 5
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 second-quarter conference call on Wednesday, February 5, 2020, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal second quarter ended December 31, 2019, and its financial outlook. CSI will issue a post-market earnings release prior to the call on February 5, 2020.
Dec 16, 2019 07:00 am ET
Cardiovascular Systems, Inc. Introduces Peripheral Orbital Atherectomy System With GlideAssist® in Europe
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS) 1.25mm Micro Crown with GlideAssist® (1.25 Micro Crown).
Nov 12, 2019 05:00 pm ET
Cardiovascular Systems, Inc. Announces Stephen Stenbeck Joins Board of Directors
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Stephen Stenbeck. He replaces independent director Brent Blackey, who is retiring after 12 years of service.
Nov 05, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Present at the Stifel 2019 Healthcare Conference
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019.
Oct 29, 2019 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2020 First-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal first quarter, ended September 30, 2019.
Oct 08, 2019 04:05 pm ET
First Patient in Middle East Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in the United Arab Emirates has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS).
Oct 08, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 First-Quarter Earnings Conference Call Tuesday, October 29
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 first-quarter conference call on Tuesday, October 29, 2019, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2019, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 29, 2019.
Sep 24, 2019 07:00 am ET
Cardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced U.S. Food and Drug Administration (FDA) PMA approval of the new ViperWire Advance® Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).
Aug 28, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Participate at Three September Investor Conferences
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will participate and host investor meetings at the following three conferences:
Aug 16, 2019 04:45 pm ET
Cardiovascular Systems Presents LIBERTY 360° Three-Year Outcomes at 2019 Amputation Prevention Symposium
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease (PAD and CAD), presented three-year outcomes from its LIBERTY 360° study in a late-breaking presentation at the 2019 Amputation Prevention Symposium (AMP) in Chicago.
Aug 12, 2019 04:05 pm ET
Cardiovascular Systems, Inc. to Feature LIBERTY 360° Three-year Outcomes Data at 2019 Amputation Prevention Symposium
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the three-year outcomes from its LIBERTY 360° study will be featured in a late-breaking presentation at the 2019 Amputation Prevention Symposium (AMP) in Chicago on Friday, August 16th. In addition, the two-year endovascular PAD-related health care costs in LIBERTY 360° and an orbital atherectomy economic sub-analysis will also be present
Aug 07, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Participate in 8th Annual Intellisight Investor Conference on August 14
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the 8th Annual Intellisight Conference in Minneapolis, Minn. on Wednesday, August 14th at 7:30 a.m. Central Time.
Aug 06, 2019 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2019 Fourth-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal fourth quarter, ended June 30, 2019.
Aug 05, 2019 07:00 pm ET
Cardiovascular Systems, Inc. Acquires Gardia Medical Ltd.'s WIRION™ Embolic Protection System
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has acquired the WIRION Embolic Protection System and related assets from Gardia Medical Ltd., a wholly owned Israeli subsidiary of Allium Medical Solutions Ltd. (TASE: ALMD).
Jul 25, 2019 04:05 pm ET
Cardiovascular Systems, Inc. Announces Former U.S. Congressman Erik Paulsen Joins Board of Directors
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after seven years of service. The CSI board continues to have seven directors, six of whom are independent.
Jul 16, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2019 Fourth-Quarter Earnings Conference Call Tuesday, August 6
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 fourth-quarter conference call on Tuesday, August 6, 2019, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal fourth quarter ended June 30, 2019, and its financial outlook. The company will issue a post-market earnings release prior to the call on August 6, 2019.
Jun 11, 2019 05:00 pm ET
Cardiovascular Systems, Inc. Announces First Patient Enrolled in REACH PVI Clinical Study
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first patient was enrolled in the REACH PVI study. The purpose of this study is to prospectively evaluate acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease (PAD) in lower extremity lesions.
Jun 11, 2019 06:00 am ET
Cardiovascular Systems, Inc. to Present at the Raymond James Life Sciences & MedTech Conference
On Tuesday, June 18, 2019, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the Raymond James Life Sciences & MedTech Conference at 9:45 a.m. Eastern Time.
May 01, 2019 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2019 Third-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal third quarter, ended March 31, 2019.
Apr 15, 2019 08:00 am ET
Report: Developing Opportunities within Toyota Motor, Red Hat, Koninklijke Philips N.V, Cardiovascular, SAP SE, and Pacific Ethanol — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Toyota Motor Corporation (NYSE:TM), Red Hat, Inc. (NYSE:RHT),...
Apr 10, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2019 Third-Quarter Earnings Conference Call Wednesday, May 1
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 third-quarter conference call on Wednesday, May 1, 2019, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2019, and its financial outlook. The company will issue a post-market earnings release prior to the call on May 1, 2019.
Mar 04, 2019 04:05 pm ET
Cardiovascular Systems, Inc. to Present at Three Upcoming Investor Conferences
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the following three conferences:
Mar 01, 2019 04:55 pm ET
Washington Real Estate Investment Trust and Cardiovascular Systems Set to Join S&P SmallCap 600
NEW YORK, March 1, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600:...
Feb 20, 2019 07:00 am ET
Cardiovascular Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference
On Wednesday, February 27, 2019, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, and Chief Operating Officer, Rhonda Robb, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. Eastern Time.
Feb 19, 2019 08:10 am ET
New Research: Key Drivers of Growth for Omega Healthcare Investors, Cinedigm, Cardiovascular, Allegiant Travel, Catalyst Biosciences, and ESCO Technologies — Factors of Influence, Major Initiatives an
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Omega Healthcare Investors, Inc. (NYSE:OHI), Cinedigm Corp...
Jan 30, 2019 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2019 Second-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal second quarter, ended December 31, 2018.
Jan 16, 2019 04:05 pm ET
First Patients in the Middle East Treated with Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in the United Arab Emirates (UAE) have been treated with its Diamondback 360® Coronary Orbital Atherectomy System (OAS).
Jan 07, 2019 07:00 am ET
Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues of $60.2 Million
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced preliminary and unaudited revenue results for its fiscal second quarter, ended December 31, 2018.
Jan 02, 2019 07:00 am ET
Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System with Classic Crown and New ViperWire Advance® FlexTip Guidewire in Japan
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that Japan’s Ministry of Health, Labor and Welfare (MHLW) has approved the Diamondback 360® Coronary Orbital Atherectomy System (OAS) with Classic Crown (Classic Crown) and ViperWire Advance® Coronary Guidewire FlexTip (FlexTip).
Dec 26, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Announces First Patients Treated in United States with OrbusNeich Teleport® Microcatheter
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the first patients in the United States were treated using the OrbusNeich® Teleport Microcatheter (Teleport), which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Nov 28, 2018 07:50 am ET
Analysis: Positioning to Benefit within Cardiovascular, Ennis, Sparton, LightPath Technologies, Blue Apron, and HFF — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cardiovascular Systems, Inc. (NASDAQ:CSII), Ennis, Inc. (NYSE:EBF),...
Nov 13, 2018 04:05 pm ET
First Patients in Europe Treated with Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Germany have been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS). The German cases represent the first commercial use of Peripheral OAS in Europe.
Nov 08, 2018 07:00 am ET
First Patient in Hong Kong Treated with Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Hong Kong has been treated with its Diamondback 360® Coronary Orbital Atherectomy System (OAS). This procedure marks the first international coronary procedure taking place as a result of the company’s distribution agreement with OrbusNeich®.
Oct 30, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first quarter, ended September 30, 2018.
Oct 18, 2018 08:00 am ET
Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular — New Hori
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Continental Building Products, Inc. (NYSE:CBPX), Hornbeck Offshore...
Oct 09, 2018 07:00 am ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 first-quarter conference call on Tuesday, October 30, 2019, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal first quarter ended September 30, 2018, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 30, 2018.
Sep 19, 2018 01:30 pm ET
Cardiovascular Systems, Inc. Announces First Commercial Launch of Peripheral Orbital Atherectomy System Outside the United States
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Hong Kong has been treated with its Stealth 360® Peripheral Orbital Atherectomy System (OAS). The Hong Kong case is the first commercial use of Peripheral OAS outside of the United States.
Aug 24, 2018 08:15 am ET
Investor Expectations to Drive Momentum within ADTRAN, GMS, Brightcove, HFF, Imperva, and Cardiovascular — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ADTRAN, Inc. (NASDAQ:ADTN), GMS Inc. (NYSE:GMS), Brightcove Inc....
Aug 08, 2018 04:05 pm ET
Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes at 2018 Amputation Prevention Symposium
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented two-year outcomes from its LIBERTY 360° study in a late-breaking presentation at the 2018 Amputation Prevention Symposium (AMP) in Chicago.
Jul 31, 2018 08:00 am ET
Cardiovascular Systems, Inc. and Aerolase Corp. Sign Collaborative Agreement for Laser Atherectomy Technology
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that it has signed an agreement with Aerolase Corp. (Aerolase®) to co-develop a new laser atherectomy device for physicians to use in more effectively treating multiple forms of arterial disease.
Jul 30, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2018 Fourth-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal fourth quarter, ended June 30, 2018.
Jul 16, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Signs International Distribution Agreement with OrbusNeich
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral Orbital Atherectomy Systems (OAS) outside the United States and Japan. OrbusNeich manufactures and sells an extensive portfolio of coronary and peripheral products including stents, balloons and microcatheters. The company operates 12 regional sales offices throughout the world and their products are currently sold in over 60 countries.
Jul 10, 2018 07:00 am ET
Cardiovascular Systems, Inc. to Release Fiscal 2018 Fourth-Quarter Results on July 30
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will release fourth-quarter results on July 30 after market close. In lieu of hosting a quarterly earnings conference call, CSI management will discuss fourth-quarter results at the beginning of its analyst day on July 31. The analyst day webcast will begin on Tuesday, July 31, 2018, at 8:00 a.m. CT (9:00 a.m. ET).
Jun 19, 2018 07:45 am ET
Detailed Research: Economic Perspectives on LSC Communications, Cardiovascular, RPX, Nustar Energy, LSB Industries, and Digi International — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LSC Communications (NYSE:LKSD), Cardiovascular Systems, Inc....
May 02, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third quarter, ended March 31, 2018.
Apr 24, 2018 07:55 am ET
Research Report Identifies Spartan Motors, Cardiovascular, Stone Energy, Verisk Analytics, National Bank, and Sonoco Products with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spartan Motors, Inc. (NASDAQ:SPAR), Cardiovascular Systems,...
Apr 11, 2018 04:05 pm ET
Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 third-quarter conference call on Wednesday, May 2, 2018, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2018, and its financial outlook. The company will issue a post-market earnings release prior to the call on May 2.
Mar 06, 2018 04:05 pm ET
Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented 18-month outcomes from its LIBERTY 360° study at the Cardiovascular Research Technologies (CRT) 2018 interventional cardiology conference in Washington, D.C. The study evaluates the acute and long-term clinical and economic outcomes of endovascular device interventions, including CSI’s orbital atherectomy
Mar 01, 2018 02:31 pm ET
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S.
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the OrbusNeich® 1.0mm Sapphire® II PRO coronary balloon.
Mar 01, 2018 07:55 am ET
Report: Developing Opportunities within Main Street Capital, United States Cellular, FibroGen, Cardiovascular, CDW, and ANSYS — Future Expectations, Projections Moving into 2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Main Street Capital Corporation (NYSE:MAIN), United...
Feb 14, 2018 07:00 am ET
Cardiovascular Systems, Inc. Announces First Patients Treated from Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today that the first patients were treated using its FDA-cleared extended length Diamondback 360® Peripheral Orbital Atherectomy Device (OAD) to treat peripheral artery disease (PAD). Dr. Mahir Elder, an interventional cardiologist at the Detroit Medical Center Heart Hospital, and Drs. Ian Cawich and Vasili Lendel,
Feb 07, 2018 04:06 pm ET
Cardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial Officer
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately. As part of a planned succession, Points succeeds Larry Betterley as CFO and will report to Scott Ward, Chairman, President and Chief Executive Officer.
Feb 07, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal second quarter, ended December 31, 2017.
Feb 07, 2018 12:45 pm ET
Cardiovascular Systems, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / Cardiovascular Systems, Inc. (NASDAQ: CSII) will be discussing their earnings results in their Q2 Earnings Call to be held on February 7, 2018 at 4:45 PM Eastern Time.
Feb 05, 2018 07:00 am ET
Cardiovascular Systems, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
On Wednesday, February 14, 2018, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the LEERINK Partners 7th Annual Global Healthcare Conference at 10:30 a.m. Eastern Time.
Feb 01, 2018 04:05 pm ET
Cardiovascular Systems, Inc. Announces Commercial Launch in Japan
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has commercially treated the first patient in Japan with its Diamondback 360® Coronary OAS Micro Crown (Micro Crown).
Jan 24, 2018 06:00 am ET
Cardiovascular Systems, Inc. Appoints Rhonda Robb as New Chief Operating Officer
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today announced that it has appointed Rhonda Robb as its new Chief Operating Officer. She will report to Scott Ward, CSI Chairman, President and Chief Executive Officer.
Jan 18, 2018 07:00 am ET
Cardiovascular Systems Expands Product Portfolio to Further Support Peripheral and Coronary Interventions
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced two new partnerships broadening the company’s product portfolio. CSI is now the exclusive U.S. distributor of OrbusNeich balloon products. Additionally, the company has signed an original equipment manufacturer (OEM) agreement with Integer Holdings Corporation for CSI-branded ZILIENT™ guidewires.
Jan 10, 2018 07:00 am ET
Cardiovascular Systems to Webcast Fiscal 2018 Second-Quarter Earnings Conference Call Wednesday, February 7
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 second-quarter conference call on Wednesday, February 7, 2018, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal second quarter ended December 31, 2017, and its financial outlook. The company will issue a post-market earnings release prior to the call on February 7.
Jan 04, 2018 07:40 am ET
Report: Exploring Fundamental Drivers Behind K2M Group, Altra Industrial Motion, FibroGen, Cardiovascular, Bluerock Residential Growth REIT, and National Presto Industries — New Horizons, Emerging Tre
NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of K2M Group Holdings, Inc. (NASDAQ:KTWO), Altra...
Nov 28, 2017 02:15 pm ET
Scott+Scott, Attorneys at Law, LLP is Investigating Derivative Claims on Behalf of Shareholders of Cardiovascular Systems, Inc. (CSII)
Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that it is investigating whether certain officers and directors of Cardiovascular Systems, Inc. (“Cardiovascular Systems” or the “Company”)
Oct 25, 2017 04:05 pm ET
Oct 12, 2017 01:27 pm ET
Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Cardiovascular Systems, Inc. (CSII)
NEW YORK, Oct. 12, 2017 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain officers and directors of Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") (NASDAQ: CSII) breached fiduciary duties owed to the Company and its shareholders.  If you are a Cardiovascular Systems shareholder, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for additional information....
Oct 09, 2017 10:33 am ET
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cardiovascular Systems, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, Oct. 9, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Cardiovascular Systems, Inc. (NASDAQ: CSII). ...
Oct 04, 2017 01:16 pm ET
Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Cardiovascular Systems, Inc. (CSII)
Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, is investigating whether certain officers and directors of Cardiovascular Systems, Inc. (“Cardiovascular Systems” or the “Company”) (NASDAQ: CSII) breached t
Oct 04, 2017 07:00 am ET
Cardiovascular Systems to Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal first quarter ended September 30, 2017, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 25.
Apr 04, 2017 10:03 am ET
Cardiovascular Systems, Inc. Secures $40 Million Line of Credit from Silicon Valley Bank
ST. PAUL, Minn., April 4, 2017 /PRNewswire/ -- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative solutions for treating peripheral and coronary vascular disease, has entered into a credit facility with Silicon Valley Bank (SVB), the bank of the world's most innovative companies and their investors. This agreement provides CSI with up to $40 million for working capital and general corporate purposes. ...
May 12, 2016 02:07 pm ET
Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
NEW YORK, May 12, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company") (NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders....
Apr 05, 2016 12:35 pm ET
Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Cardiovascular Systems Inc. To Contact The Firm Before Upcoming Lead Plaintiff Deadl
NEW YORK, April 5, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardiovascular Systems Inc. ("Cardiovascular" or the "Company") (NASDAQ:CSII) of the April 12, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. ...
Apr 04, 2016 09:00 am ET
Important Lead Plaintiff Deadline Reminder for Cardiovascular Systems Shareholders From Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP reminds Cardiovascular Systems, Inc. (NASDAQ: CSII) ("CSI" or the "Company") shareholders that a class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf...
Mar 22, 2016 11:59 am ET
INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Cardiovascular Systems, Inc. and a Lead Plaintiff Deadline of April 12, 2016 - CSII
NEW YORK, March 22, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Cardiovascular Systems, Inc. (NASDAQ: CSII) securities between September 12, 2011 and January 21, 2016....
Mar 04, 2016 04:13 pm ET
Kessler Topaz Meltzer & Check, LLP Files Shareholder Class Action Lawsuit Against Cardiovascular Systems, Inc. - CSII
RADNOR, Pa., March 4, 2016 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a shareholder class action lawsuit in the United States District Court for the District of Minnesota against Cardiovascular Systems, Inc. (NASDAQ: CSII) ("CSI" or the "Company") on behalf of purchasers of the Company's common stock between September 12, 2011 and January 21, 2016, inclusive (the "Class Period")....
Feb 29, 2016 09:11 am ET
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
MERION, Pa., Feb. 29, 2016 /PRNewswire/ -- The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:...
Feb 26, 2016 04:15 pm ET
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Cardiovascular Systems Inc.
WAYNE, Pa., Feb. 26, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Central District of California on behalf of all persons or entities that purchased Cardiovascular Systems, Inc. (NASDAQ: CSII) ("CSI" or the "Company") securities between September 12, 2011 and January 21, 2016, inclusive (the "Class Period")....
Feb 23, 2016 02:53 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cardiovascular Systems, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of April 12, 2016 -- CSII
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cardiovascular Systems, Inc. ("Cardiovascular Systems") (NASDAQ: CSII) between September 12,...
Feb 19, 2016 01:04 pm ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Cardiovascular Systems Inc. to Contact the Firm Before Lead Plaintiff Deadline
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardiovascular Systems Inc. ("Cardiovascular" or the "Company") (NASDAQ: CSII) of the April 12, 2016 deadline to seek the role of lead plaintiff in a federal...
Feb 18, 2016 06:39 pm ET
Shareholder Class Action Filed Against Cardiovascular Systems, Inc. - CSII
RADNOR, Pa., Feb. 18, 2016 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Cardiovascular Systems, Inc. (NASDAQ: CSII) ("CSI" or the "Company") on behalf of purchasers of the Company's securities between September 12, 2011 and January 21, 2016, inclusive (the "Class Period")....
Feb 18, 2016 06:35 pm ET
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cardiovascular Systems, Inc. - CSII
BALA CYNWYD, Pa., Feb. 18, 2016 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces an investigation of Cardiovascular Systems, Inc ("Cardiovascular Systems" or the "Company") (Nasdaq -CSII- News) for potential violations of federal securities laws and breaches of the Cardiovascular Systems Board's fiduciary duties. ...
Feb 16, 2016 11:42 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Cardiovascular Systems, Inc. (CSII) and Lead Plaintiff Deadline: April 12, 2016
NEW YORK, Feb. 16, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") (NASDAQ: CSII).  The class action has been filed on behalf of a class consisting of all persons or entities who purchased Cardiovascular Systems, Inc. securities during the period between September 12, 2011 and January 21, 2016 inclusive (the "Class Period").  ...